Roche Venture Fund is the corporate venture capital arm of Roche, a global leader in pharmaceuticals and diagnostics. The fund focuses on investing in private life science companies with innovative medicines, diagnostics, and technologies, aiming to create value by fostering innovation, guiding successful businesses, and generating financial returns to Roche. With a CHF 750 million evergreen fund, Roche Venture Fund actively involves itself within its portfolio companies, providing not just funding but also expertise and long-term vision to drive shared success.
Is Roche Venture Fund the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Roche Venture Fund, along with a list of other relevant VCs, is available on Hopohopo.io.
Investment role
Lead and follow
Stages
Series A
First ticket size
CHF 3,000,000 - CHF 10,000,000
When approaching Roche Venture Fund, founders should highlight how their technology or therapeutic platform can strategically complement or extend Roche’s existing capabilities in pharmaceuticals or diagnostics. Emphasize robust scientific validation, clear differentiation from competitors, and a pathway to clinical or commercial impact. Demonstrating a collaborative mindset and openness to leveraging Roche’s global resources and expertise will resonate, as the fund values partnerships that can scale innovation within the broader healthcare ecosystem.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.